vimarsana.com
Home
Live Updates
Veracyte's Decipher Prostate Test Receives Highest Evidence-
Veracyte's Decipher Prostate Test Receives Highest Evidence-
Veracyte's Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines -February 27, 2024 at 05:56 pm EST
Veracyte, Inc. , a leading cancer diagnostics company, today announced that its Decipher Prostate Genomic Classifier is the only gene expression test to receive a “Level 1B” evidence rating in...
Related Keywords
Elai Davicioni ,
Nasdaq ,
Twitter ,
National Comprehensive Cancer Network ,
Veracyte Inc ,
Decipher Prostate Genomic Classifier ,
Clinical Practice Guidelines ,
Decipher Prostate ,
Decipher Prostate Genomic ,
Veracyte Diagnostics Platform ,
Annual Report ,
Quarterly Report ,
National Comprehensive Cancer ,
Markets ,